Brief: Ono Pharma: Entered Into Research Collaboration Agreement With Inveniai To Identify Novel Therapeutic Targets
19/02/2024 10:35
Feb 19 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T :
* ONO PHARMA: ENTERED INTO RESEARCH COLLABORATION AGREEMENT
WITH
INVENIAI TO IDENTIFY NOVEL THERAPEUTIC TARGETS
Source text for Eikon: ID:
Further company coverage: 4528.T
(Reporting by Rocky Swift)
((rocky.swift@thomsonreuters.com;))
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours